Literature DB >> 1095479

In vitro lymphocyte response to purified protein derivative, BCG and Mycobacterium leprae in a population not exposed to leprosy.

O Closs.   

Abstract

Lymphocytes from 14 BCG-vaccinated donors, seven tuberculin positive and seven tuberculin negative by skin testing, were stimulated in vitro with four mycobacterial antigens, purified protein derivative (PPD), PPD/BCG, whole BCG bacilli, and whole Mycobacterium leprae and also with Candida antigen and phytohemagglutinin. The response was measured by incorporation of (3)H-labeled thymidine. The response to PPD, PPD/BCG, and BCG was found to correlate with the result of skin testing with turberculin. The turberculin-positive group also responded more strongly to M. leprae, whereas the two groups did not differ significantly in their response to Candida antigen or phytohemagglutinin. These findings indicate a certain degree of cross-reactivity between BCG and M. leprae. The use of the lymphocyte transformation test to measure antigenic cross-reactivity is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1095479      PMCID: PMC415194          DOI: 10.1128/iai.11.6.1163-1169.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Lepromin and tuberculin reactivity in adults not exposed to leprosy.

Authors:  C C Shepard; E W Saitz
Journal:  J Immunol       Date:  1967-10       Impact factor: 5.422

2.  Reactivity of human lymphocytes to aggregated and nonaggregated PPD-tuberculin.

Authors:  B S Nilsson; G Möller
Journal:  Cell Immunol       Date:  1972-12       Impact factor: 4.868

3.  The response of lymphocytes from tuberculin-positive or negative humans to various doses of PPD-tuberculin in vitro.

Authors:  B S Nilsson
Journal:  Cell Immunol       Date:  1972-03       Impact factor: 4.868

4.  In vitro lymphocyte responses and skin test reactivity following BCG vaccination.

Authors:  J W Thomas; D Clements; S Grzybowski
Journal:  Clin Exp Immunol       Date:  1971-11       Impact factor: 4.330

5.  Skin hypersensitivity and in vitro lymphocytic reactivity to tuberculin in childhood.

Authors:  N Matsaniotis; C Tsenghi; C Economou-Mavrou; C Metaxotou-Stavridaki
Journal:  J Pediatr       Date:  1968-05       Impact factor: 4.406

6.  Quantitative aspects of the stimulation of lymphocytes by tuberculin purified protein derivative.

Authors:  C F Hinz; T M Daniel; G L Baum
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

7.  Studies of immune mechanisms in leprosy. 3. The role of cellular and humoral factors in impairment of the in vitro immune response.

Authors:  W E Bullock; P Fasal
Journal:  J Immunol       Date:  1971-04       Impact factor: 5.422

8.  Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes.

Authors:  T Godal; B Myklestad; D R Samuel; B Myrvang
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

Review 9.  Immunological phenomena in leprosy and related diseases.

Authors:  J L Turk; A D Bryceson
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

10.  Transformation of leprous lymphocytes by leprolin, tuberculin and phytohemagglutinin.

Authors:  S H Han; R S Weiser; Y C Lin
Journal:  Int J Lepr Other Mycobact Dis       Date:  1971 Oct-Dec
View more
  7 in total

1.  In vitro lymphocyte stimulation in leprosy; simultaneous stimulation with Mycobacterium leprae antigens and phytohaemagglutinin.

Authors:  G Bjune
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

2.  In vitro stimulation of lymphocytes with an antigen fraction prepared from Mycobacterium leprae and tuberculin PPD in contacts and non-contacts of leprosy patients.

Authors:  L J Reitan; O Closs
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

3.  Plasma factors in delayed-type hypersensitivity. Augmentation of lymphocyte responses in borderline leprosy reactions.

Authors:  G Bjune; R S Barnetson
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

4.  Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions.

Authors:  G Bjune; R S Barnetson; D S Ridley; G Kronvall
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

5.  Lymphocyte response of leprosy patients to human-derived and purified armadillo-derived Mycobacterium leprae, BCG and PPD.

Authors:  A H Smelt; F Y Liew; R J Rees
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

6.  Comparative studies of antigen 21 in Mycobacterium and Nocardia species: possible taxonomic relationships with Mycobacterium leprae.

Authors:  K Widebäck; G Kronvall; B Bjorvatn; O Closs; M Harboe
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

7.  The effect of delayed addition of antigen and 'E' rosetting on the proliferative response to mycobacterial antigens of peripheral blood lymphocytes from normal individuals or from patients with tuberculosis or leprosy.

Authors:  G M Bahr; G A Rook; J L Stanford; P M Lydyard; A D Bryceson
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.